Collectively, with many reports presenting TRIM28 contribution to cancer, these findings suggest that regulatory networks controlling self-renewal in stem cells may also be active in some types of cancer and may constitute new cancer cell therapy. This evidence concerns the gene TRIM28 and cancer.